Eiffel names CEO as executive director
Monday, 02 June, 2003
Eiffel Technologies' CEO Christine Cussen has joined the company's board as an executive director.
Formerly managing director of AstraZeneca Pharmaceuticals, Cussen joined Melbourne-based Eiffel in October 2000 to oversee the development and commercialisation of the company's supercritical fluid technologies.
"She has brought strong professional marketing and management expertise to Eiffel at a time when we were seeking to increase the exposure of our technologies to our customer base and international pharmaceutical companies worldwide. She is a very valued employee and we recognise that she will make a significant contribution at Board level to the success of the company," said chairman Tom Hartigan.
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
Novel glycopeptide antibiotic candidate shows promise
Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...
